RxDoctor Payments DataLook up a doctor →

Wayne Moschetti

Adult Reconstructive Orthopaedic Surgery · Lebanon, NHNPI 1487871828

Payments from drug & device makers

$785,128in general payments, 2019–2025

Across 613 payments — averaging $1280.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$423K
  • Depuy Synthes Products, Inc.$145K
  • Smith+Nephew$108K
  • Medacta USA, Inc.$97K
  • Linkbio Corp$7K
  • Zimmer Biomet$3K
  • plus $2K from 5 others
$62,246in research payments, 2019–2025

Across 8 payments — averaging $7780.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$34K
  • Medacta USA, Inc.$28K

What the payments were for

  • Consulting fees$384,36881%
  • Speaking & faculty fees$31,6257%
  • Travel & lodging$47,25810%
  • Food & beverage$12,4083%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in New Hampshireto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$310,709
Medicare patients
452
Services billed
694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib25$839
Oxycodone Hcl60$260
Gabapentin15$163
Meloxicam18$47
Tramadol Hcl14$45

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Lebanon

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →